Press Releases

Webcast
SVB Leerink Global Healthcare Conference
Thursday, February 27, 2020 11:00 am EST
Date Title
04/24/17
Summary ToggleT2 Biosystems Announces 2017 First Quarter Financial and Operational Results Release and Conference Call Date Printer Friendly Version LEXINGTON, Mass. , April 24, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2017 first quarter financial and operational results after the market closes on Tuesday, May 2, 2017 . In conjunction with the release, the Company will host a conference
04/19/17
Summary ToggleT2 Biosystems to Host Symposium at 27th European Congress of Clinical Microbiology and Infectious Diseases Printer Friendly Version Speakers to review clinical and economic benefits of direct-from-whole-blood identification of sepsis pathogens LEXINGTON, Mass. , April 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that the company will be hosting a special symposium highlighting the clinical and
03/28/17
Summary ToggleT2 Biosystems to Present at the Needham Healthcare Conference Printer Friendly Version LEXINGTON, Mass. , March 28, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough , president and chief executive officer, is scheduled to attend and present at the Needham Healthcare Conference on Wednesday, April 5, 2017 at 11:20am ET at the Westin New
02/13/17
Summary ToggleT2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results Printer Friendly Version LEXINGTON, Mass. , Feb. 13, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc . (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, today announced operating highlights and financial results for the
02/06/17
Summary ToggleT2 Biosystems to Present at the Leerink Global Healthcare Conference Printer Friendly Version LEXINGTON, Mass. , Feb. 06, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough , president and chief executive officer, and Shawn Lynch , chief financial officer, are scheduled to attend and present at the Leerink Global Healthcare Conference on
02/03/17
Summary ToggleT2 Biosystems Announces 2016 Fourth Quarter and Full-Year Results Release and Conference Call Date Printer Friendly Version LEXINGTON, Mass. , Feb. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2016 fourth quarter and full-year financial results after the market closes on Monday, February 13 , 2017.  In conjunction with the release, the Company will host a
01/30/17
Summary ToggleStudy Published in the American Journal of Clinical Pathology Highlights Rapid Detection of Platelet Function Using T2MR® Technology Printer Friendly Version Study Shows T2MR’s Sensitive Detection of Platelet Function at Similar or Lower Platelet Counts than Traditional Tests  Paper Provides Novel Insight Into Platelet Biology Not Evident Using Plasma-Based Platelet Aggregation Tests LEXINGTON, Mass. , Jan.
01/25/17
Summary ToggleT2 Biosystems to Host Webinar on the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship Printer Friendly Version Webinar to be hosted by Dr. Michael A. Pfaller, Chief Medical Officer LEXINGTON, Mass. , Jan. 25, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare
01/09/17
Summary ToggleT2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress Printer Friendly Version  -- On Track to Meet or Exceed Commercial Guidance and Regulatory Timelines -- LEXINGTON, Mass. , Jan. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare
01/05/17
Summary ToggleT2 Biosystems, Inc. Announces $50M Credit Facility Printer Friendly Version -- Retiring Former Debt Facility; Significantly Decreases Near-Term Cash Needs -- LEXINGTON, Mass. , Jan. 05, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products that improve patient health and deliver a strong economic return to